Elizabeth Yeu-Lin, M.D.

Elizabeth Yeu-Lin, M.D.

Chief Medical OfficeratTarsus Pharmaceuticals· In proxies 2023–2024

Pay in FY2024Tarsus Pharmaceuticals stock +173.4% the same year

Elizabeth Yeu-Lin, M.D. was paid $3.1M in FY2024 (Dec). Tarsus Pharmaceuticals stock rose 173.4% that year.

Pay$100 in the stock at the end of FY23 → $273
Pay is from the Summary Compensation Table of each Tarsus Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tarsus PharmaceuticalsPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role +407%
  2. STAAR Surgical CompanyPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?